Cardiovascular Event Rates in Statin-Treated Korean Patients with Cardiovascular Disease: Estimates from a Real-World Population Using Electronic Medical Record Data.
Osung KwonWonjun NaJaehee HurJu Hyeon KimTae Joon JunHee Jun KangHojoon LeeYoung Hak KimPublished in: Cardiovascular drugs and therapy (2021)
By analyzing EMR data representing routine practice in Korea, we found that patients with very high-risk ASCVD were at substantial risk of further cardiovascular events in 3 years. Given the observed risk of recurrent events with suboptimal lipid management by statin, additional treatment to control LDL-C might be necessary to reduce the burden of further cardiovascular events for very high-risk ASCVD patients.
Keyphrases
- cardiovascular events
- cardiovascular disease
- coronary artery disease
- newly diagnosed
- end stage renal disease
- electronic health record
- healthcare
- cardiovascular risk factors
- primary care
- prognostic factors
- type diabetes
- clinical practice
- data analysis
- deep learning
- low density lipoprotein
- quality improvement
- replacement therapy
- patient reported